| |
| |
|
| Insider
Information: |
Martin G. Kelly |
| Relationship: |
CEO and President, Dir... |
| City: |
Anaheim |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
60,000 |
|
|
Indirect Shares
|
45,000 |
|
|
| Direct
Value |
$50,100 |
|
|
|
Indirect Value
|
$37,575 |
|
|
| Total
Shares |
105,000 |
|
|
| Total
Value |
$87,675 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Questcor Pharmaceuticals Inc |
QCOR |
Director |
2014-08-14 |
0 |
2013-11-09 |
0 |
Premium* |
|
|
Novan, Inc. |
NOVN |
Chief Executive Office... |
2019-05-29 |
60,000 |
2019-05-29 |
45,000 |
Premium* |
|
|
Radius Health Inc. |
RDUS |
CEO and President, Dir... |
2022-08-15 |
0 |
2022-02-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RDUS |
Radius Health Inc. |
CEO and President |
• • – |
2022-08-15 |
4 |
D |
$10.00 |
$750,000 |
D/D |
(75,000) |
0 |
0 |
- |
|
| RDUS |
Radius Health Inc. |
CEO and President |
• • – |
2022-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
75,000 |
0 |
- |
|
| RDUS |
Radius Health Inc. |
CEO and President |
• • – |
2022-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
960,000 |
960,000 |
0 |
- |
|
| NOVN |
Novan, Inc. |
Chief Executive Officer |
• • – |
2019-05-29 |
4 |
B |
$1.97 |
$2,955 |
I/I |
1,500 |
45,000 |
2.58 |
- |
|
| NOVN |
Novan, Inc. |
Chief Executive Officer |
• • – |
2019-05-28 |
4 |
B |
$2.15 |
$7,525 |
I/I |
3,500 |
43,500 |
2.58 |
- |
|
| NOVN |
Novan, Inc. |
Chief Executive Officer |
• • – |
2019-05-17 |
4 |
B |
$1.43 |
$57,200 |
I/I |
40,000 |
40,000 |
2.66 |
- |
|
| NOVN |
Novan, Inc. |
Chief Executive Officer |
• • – |
2019-05-17 |
4 |
B |
$1.43 |
$28,600 |
D/D |
20,000 |
60,000 |
2.81 |
- |
|
| NOVN |
Novan, Inc. |
Chief Executive Officer |
• • – |
2018-09-26 |
4 |
B |
$2.73 |
$27,300 |
D/D |
10,000 |
40,000 |
2.81 |
- |
|
| NOVN |
Novan, Inc. |
Chief Executive Officer |
• • – |
2018-08-21 |
4 |
B |
$2.71 |
$81,300 |
D/D |
30,000 |
30,000 |
2.81 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Director |
– • – |
2014-08-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,812) |
0 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Director |
– • – |
2013-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,812 |
2,812 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
